CII
SNY icon

CR Intrinsic Investors’s Sanofi SNY Stock Holding History

CR Intrinsic Investors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-125,000
Closed -$6.33M – 352
2013
Q3 		$6.33M Buy
+125,000
New +$6.36M 0.2% 166

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

CR Intrinsic Investors's SNY Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Sanofi (SNY) in Q4 2013, closing a stake of 125,000 shares — an estimated $6.33M sold.

CR Intrinsic Investors first reported a position in SNY in Q3 2013 and held it in 1 quarter. The position peaked at $6.33M in Q3 2013. 487 funds tracked by Wall St. Rank hold SNY as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Sanofi position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 125,000 Sanofi shares in Q4 2013, an estimated $6.33M.
  • CR Intrinsic Investors first reported a position in Sanofi in Q3 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Sanofi position peaked at $6.33M in Q3 2013.
  • 487 funds tracked by Wall St. Rank held Sanofi as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.